Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Cold Agglutinin Disease: Virtual Patient Simulation Improves Performance in Diagnosis and Management

S Christy Rohani-Montez, Michelle Arielle Worst, Stephanie Baumhover, Alyssa Mitarotondo, Emily Mikhael, Sigbjørn Berentsen, Roy Smith

Blood (2024) 144 (Supplement 1): 2444.

https://doi.org/10.1182/blood-2024-207690

Published: 2024

Journal Articles

Gene Expression Analysis Reveals Downregulation of Complement Receptor 1 in Cold Agglutinin Disease

Agnieszka Malecka, Ingunn Ostlie, Gunhild Trøen, Jędrzej M. Małecki, Jan Delabie, Anne Tierens, Sigbjørn Berentsen, Geir E Tjønnfjord

Blood (2022) 140 (Supplement 1): 6419–6420.

https://doi.org/10.1182/blood-2022-156489

Published: 2022

Journal Articles

Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)

Blood (2022) 140 (Supplement 1): 2825–2827.

https://doi.org/10.1182/blood-2022-159562

Published: 2022

Journal Articles

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M. I. Vos, Michael Storek, Nancy Wong, Parija Patel, Xiaoyu Jiang, Deepthi S. Vagge, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M. Broome

Blood (2022) 140 (9): 980–991.

https://doi.org/10.1182/blood.2021014955

Published: 2022

Includes: Supplemental data

Journal Articles

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome

Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, Steven P. Treon, Marjan Cruijsen, Bruno Fattizzo, Ramona Cassin, Despina Fotiou, Efstathios Kastritis, Masja De Haas, Liesbeth E. M. Oosten, Henrik Frederiksen, Andrea Patriarca, Shirley D'Sa, Josephine M.I. Vos

Blood (2021) 138 (20): 2002–2005.

https://doi.org/10.1182/blood.2021012039

Published: 2021

Includes: Supplemental data

Journal Articles

Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study

Blood (2021) 138 (Supplement 1): 349.

https://doi.org/10.1182/blood-2021-148066

Published: 2021

Journal Articles

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist

Blood (2021) 138 (Supplement 1): 849.

https://doi.org/10.1182/blood-2021-151615

Published: 2021

Journal Articles

How I treat cold agglutinin disease

Sigbjørn Berentsen

Blood (2021) 137 (10): 1295–1303.

https://doi.org/10.1182/blood.2019003809

Published: 2021

Journal Articles

The Mutational Landscape of Cold Agglutinin Disease

Agnieszka Malecka, PhD, Gunhild Trøen, PhD, Jan Delabie, MDPhD, Ingunn Ostlie, Anne Tierens, MD PhD, Ulla Randen, MD PhD, Sigbjørn Berentsen, Geir Erland Tjønnfjord, MD PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-133760

Published: 2020

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Alexander Röth, MD, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, MD, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, William Hobbs, Sigbjørn Berentsen

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138909

Published: 2020

Journal Articles

Effective Treatment of Cold Agglutinin Disease/Cold Agglutinin Syndrome with Ibrutinib: An International Case Series

Marit Jalink, Sigbjørn Berentsen, Jorge J. Castillo, MD, Steven Treon, Bruno Fattizzo, MD, Ramona Cassin, MD, Masja De Haas, Andrea Patriarca, MD, Shirley D'Sa, MD FRCPath, Josephine M.I Vos

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139131

Published: 2020

Journal Articles

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Blood (2020) 136 (4): 480–488.

https://doi.org/10.1182/blood.2020005674

Published: 2020

Includes: Supplemental data

Journal Articles

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Alexander Röth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Stella Lin, Xiaoyu Jiang, Caroline Reuter, William Hobbs, Sigbjørn Berentsen

Blood (2019) 134 (Supplement_2): LBA-2.

https://doi.org/10.1182/blood-2019-132490

Published: 2019

Journal Articles

Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia

Bruno Fattizzo, MD, Marc Michel, Laetitia Languille, Juri Giannotta, MD, Henrik Frederiksen, MD Prof, Francesca Romana Mauro, MD, Bernd Jilma, Elisa Lucchini, MD, Andrea Patriarca, MD, Francesco Zaja, MD, Anita Hill, MD PhD, Sigbjorn Berentsen, MD PhD, Wilma Barcellini

Blood (2019) 134 (Supplement_1): 3516.

https://doi.org/10.1182/blood-2019-125524

Published: 2019

Journal Articles

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Agnieszka Malecka, Jan Delabie, MD PhD, Ingunn Ostlie, Anne Tierens, MD PhD, Ulla Randen, MD PhD, Sigbjorn Berentsen, MD PhD, Geir Erland Tjønnfjord, MD PhD, Gunhild Trøen

Blood (2019) 134 (Supplement_1): 1488.

https://doi.org/10.1182/blood-2019-121750

Published: 2019

Journal Articles

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Sarah A Lau-Braunhut, MD, Hannah Stone, Griffin Collins, MD, Sigbjørn Berentsen, MD PhD, Matt Zinter, MD, Benjamin Braun, MD PhD

Blood (2019) 134 (Supplement_1): 4798.

https://doi.org/10.1182/blood-2019-126365

Published: 2019

Journal Articles

Cold agglutinins: fending off the attack

Sigbjørn Berentsen

Blood (2019) 133 (9): 885–886.

https://doi.org/10.1182/blood-2019-01-894303

Published: 2019

Journal Articles

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Sigbjørn Berentsen, Ulla Randen, Markku Oksman, Henrik Birgens, Tor Henrik Anderson Tvedt, Jakob Dalgaard, Eivind Galteland, Einar Haukås, Robert Brudevold, Jon Hjalmar Sørbø, Inger Anne Næss, Agnieszka Malecka, Geir E. Tjønnfjord

Blood (2017) 130 (4): 537–541.

https://doi.org/10.1182/blood-2017-04-778175

Published: 2017

Journal Articles

High Frequency of Somatic Mutations of KMT2D and CARD11 Genes in Cold Agglutinin Disease

Agnieszka Malecka, Gunhild Trøen, PhD, Anne Tierens, Ingunn Østlie, Jedrzej Malecki, PhD, Ulla Randen, MD PhD, Sigbjørn Berentsen, MD PhD, Geir E. Tjønnfjord, Jan M.A. Delabie, MD PhD

Blood (2016) 128 (22): 2934.

https://doi.org/10.1182/blood.V128.22.2934.2934

Published: 2016

Journal Articles

Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)

Agnieszka Malecka, Gunhild Trøen, PhD, Anne Tierens, MD PhD, Ingunn Østlie, Ulla Randen, MD PhD, Sigbjorn Berentsen, MDPhD, Geir Tjønnfjord, MD PhD, Jan M.A. Delabie, MD PhD

Blood (2015) 126 (23): 4137.

https://doi.org/10.1182/blood.V126.23.4137.4137

Published: 2015

NARROW

Cold Agglutinin Disease: Virtual Patient Simulation Improves Performance in Diagnosis and Management

Gene Expression Analysis Reveals Downregulation of Complement Receptor 1 in Cold Agglutinin Disease

Sustained Complement C1s Inhibition with Sutimlimab in Patients with Cold Agglutinin Disease Results in Continued Efficacy during Part B of the Randomized Placebo-Controlled Phase 3 Cadenza Study (NCT03347422)

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial

Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome

Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

How I treat cold agglutinin disease

The Mutational Landscape of Cold Agglutinin Disease

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up

Effective Treatment of Cold Agglutinin Disease/Cold Agglutinin Syndrome with Ibrutinib: An International Case Series

Cold agglutinin disease revisited: a multinational, observational study of 232 patients

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Predictors of Response to Erythropoietin in Autoimmune Hemolytic Anemia

Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Cold agglutinins: fending off the attack

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

High Frequency of Somatic Mutations of KMT2D and CARD11 Genes in Cold Agglutinin Disease

Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only